
Drive sustainable change for the haemophilia and haemoglobinopathies community across Latin America, building partnerships that create lasting local impact.
Your new role
As a Project Management Specialist for the Novo Nordisk Haemophilia Foundation, you'll oversee project and portfolio management across Latin America, driving sustainable local outcomes and creating measurable impact for communities living with haemophilia and haemoglobinopathies. You will be based in Panama City on a fixed-term contract for 2 years. Initially, covering the full Latin America region during a maternity leave period, you'll then focus on Central America, the Caribbean, and Mexico.
Your day-to-day responsibilities will include:
Your new department
You'll be part of the Novo Nordisk Haemophilia Foundation (NNHF) team, reporting directly to the Head of Programmes. Working collaboratively with team members responsible for South America and other regions, you'll help drive the Foundation's mission to improve care and quality of life for people living with haemophilia and haemoglobinopathies. This is a unique opportunity to combine project management expertise with meaningful social impact across Latin America.
Your skills & qualifications
We're looking for an experienced project management professional with a passion for healthcare development and the ability to thrive in a multicultural, nonprofit environment. You'll bring:
Working at Novo Nordisk Haemophilia & Haemoglobinopathies Foundation (NNHF)
The Novo Nordisk Haemophilia & Haemoglobinopathies Foundation (NNHF) is a non-profit organisation improving access to care for people with haemophilia and haemoglobinopathies in low- and middle-income countries. The NNHF funds projects that build capacity for diagnosis and care, strengthen infrastructure, and drive data-based advocacy. Its partnership-based approach allows for custom-tailored solutions, rooted in each nation’s context. Together with its partners, the NNHF paves the way for projects to become self-sufficient and encourages systemic change to improve care for all people with haemophilia, sickle cell disease or thalassaemia.
What we offer
This is a fixed-term contract for 2 years based in Panama City, offering you the opportunity to make a meaningful difference across Latin America. Being part of a global healthcare company means opportunities to learn and develop are all around us, while our benefits are designed with your career and life stage in mind.
Deadline
5th May 2026. Applications are reviewed on an ongoing basis. Only CVs in English will be considered.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html